Jonathan Willmer MD, FRCPC


Dr. Willmer currently holds the position of Senior Medical Director, Head of Clinical Neurology, Global Research and Early Development, at EMD Serono in Boston, Massachusetts. He is responsible for early clinical development in neurodegenerative diseases.

Prior to this he held the position of Chief Medical Officer, Neurokine Pharmaceuticals Inc. a start up biotechnology company located in Vancouver, British Columbia, Canada. The company focuses on development of treatments for chronic inflammatory and degenerative central nervous system diseases. Prior to this, Dr. Willmer held the position of Chief Medical Officer, Cantest Clinical Research (formerly Prime Trials Inc.; formerly CroMedica Prime), a clinical pharmacology unit located in Vancouver, British Columbia, Canada. 

In addition, he performed independent consulting for the biotechnology, pharmaceutical, and contract research industry, primarily in the area of central nervous system drug development and clinical pharmacology.  Prior to this he held the positions of Vice President, Medical Affairs and Vice President, Clinical Development for CroMedica Global Inc., a global CRO. In these roles he was responsible for the integration of CroMedica’s global medical operations team and led CroMedica’s early clinical development programs worldwide. He oversaw the construction of and supervised the operation of CroMedica Prime, a phase 1 unit located in the Vancouver Hospital and Health Sciences Center, the major teaching hospital of the University of British Columbia.  

Prior to joining CroMedica, Dr. Willmer ran a clinical and research program in Alzheimer’s disease and dementia at the University of Ottawa (Ottawa, Ontario, Canada). For twelve years he ran a clinical trials unit in dementia, conducting trials in all phases of development. He also held a position in the Faculty of Medicine as an assistant professor. Dr. Willmer obtained his MD degree from Queen’s University (Kingston, Ontario, Canada) in 1980, and was certified in neurology by the Royal College of Physicians and Surgeons of Canada in 1985.

Corporate Updates

Captcha Image